Monash-based cancer researchers involved in collaborative research programs focused on children’s cancers, genomic risk profiling and cancer co-morbidities were beneficiaries of the latest Medical Research Future’s Fund grant, announced by the Federal Minister for Health, The Hon Greg Hunt on 30 June. Associate Professor Ron Firestein, Head of the Centre [...]
The Prostate Cancer Outcomes Registry - Victoria (PCOR-Vic) at Monash University’s School of Public Health and Preventive Medicine, has been working with survivors of prostate cancer to co-design a new online support portal for Victorian men living with the disease. The BroSupPORT portal allows men to compare their prostate cancer [...]
Participating in life saving oncology clinical trials will soon become a more available option for cancer patients throughout Gippsland, following recommencement of the MPCCC’s Monash-Gippsland tele-trials project this month. With continued funding from the Victorian Government, the project will move into its next phase which involves establishing dedicated tele-trial clinics, [...]
The uptake of telehealth by both patients and health professionals during COVID-19 presents a unique opportunity to reform the future care of people with cancer and many other health conditions. Published last month in the Internal Medical Journal (IMJ), 'Telehealth in cancer care: during and beyond the COVID‐19 pandemic' provides expert guidance [...]
This World Cancer Day, the MPCCC is celebrating the invaluable contribution of consumer and community involvement in supporting and prioritising cancer research. We asked our five Consumer and Community Representatives from the MPCCC Advisory Group to share their aspirations for the future focus of cancer research. Vivienne Interrigi, who received [...]
Prostate cancer clinical trial ENZAMET has won a trifecta of prestigious awards at the 2020 Australian Clinical Trials Alliance (ACTA) Summit. In a first for these awards, ENZAMET was awarded the ACTA Trial of the Year Award, the ACTA STInG Award for Excellence in Trial Statistics and the ACTA Consumer [...]
Clinicians and patients across MPCCC partner health services have enthusiastically responded to the MPCCC Precision Oncology Program in 2020, and this month the program has reached a new milestone: 100 patients have been referred for molecular tumour profiling. The MPCCC’s partnership with Omico, a national research program based in Sydney, has [...]
The MPCCC 2019–2020 Annual Report contains a rich and exciting account of our progress over the past financial year. Central to the achievements of the MPCCC is the talent and leadership of the cancer researchers and health professionals across our partnership, and their dedication to the community we serve. The support [...]
The MPCCC is delighted to welcome five new community members with lived experiences of cancer to its Advisory Group, whose multidisciplinary representatives will play a central role in providing strategic direction to the MPCCC. With the addition of its new community members, the MPCCC has now doubled its cohort of [...]
Molecular profiling of solid tumours is now more accessible for people with cancer, who are being treated across south-eastern Victoria, following the establishment of the MPCCC Precision Oncology Program. Over 80 patients with rare, therapy-resistant or advanced stage cancers have already been referred for screening through the MPCCC across a range of tumour [...]
